Glasky M S, Reading C L
Department of Tumor Biology, University of Texas M.D. Anderson Cancer Center, Houston.
Hybridoma. 1989 Aug;8(4):377-89. doi: 10.1089/hyb.1989.8.377.
We have examined variables leading to the generation of stable, antigen-specific, human immunoglobulin-secreting cell lines. Peripheral blood B lymphocytes enriched for Thomsen-Friedenreich antigen (T antigen)-specific cells were transformed with Epstein-Barr virus. Lymphoblastoid cells (LC) reactive with T antigen were either expanded without cloning or cloned at limiting dilution and then fused with murine 653 cells. Uncloned LCs from three transformations secreting polyclonal anti-T antibody (7-18 micrograms/ml/10(6) cells/24 hr total immunoglobulin) were subcultured at 100 cells/well, and T antigen-reactive cultures pooled. These cultures quickly lost specific antibody secretion, presumably due to overgrowth by clones of unknown specificity. T antigen-reactive LCs that were cloned three times at limiting dilution secreted 0.2 - 6.1 micrograms/ml/10(6) cells/24 hr but died or stopped secreting specific immunoglobulin after 77 to 155 days in culture. Pooling T antigen-reactive clones after each cloning step did not increase the long term stability compared to unpooled clones (p = 0.2). Fusions between cloned LCs and 653 cells failed to yield viable hybrids in nine of ten attempts with seven different LC lines. In contrast, fusion of uncloned LCs and 653 cells resulted in the generation of viable immunoglobulin-secreting heterohybrids in 22 of 24 fusions. The heterohybridomas produced from fusion of uncloned T antigen-reactive cultures with 653 cells secreted significantly more antibody (frequency of cell lines secreting greater than 2 micrograms/ml/10(6) cells/24 hr, p less than 0.01) and higher titers of antibody (frequency of cell lines secreting greater than four hemagglutination units of T antigen-specific antibody, p less than 0.03) than cloned lymphoblastoid cells. The hybrids maintained specific immunoglobulin secretion for longer in culture than either cloned or uncloned lymphoblastoid cell lines (p less than 0.001).
我们研究了导致稳定的、抗原特异性的、分泌人免疫球蛋白细胞系产生的变量。用爱泼斯坦 - 巴尔病毒转化富含针对桑德森 - 弗里德赖希抗原(T抗原)特异性细胞的外周血B淋巴细胞。与T抗原反应的淋巴母细胞(LC)要么不经过克隆进行扩增,要么通过有限稀释进行克隆,然后与鼠653细胞融合。来自三次转化的未克隆LC分泌多克隆抗T抗体(7 - 18微克/毫升/10⁶个细胞/24小时总免疫球蛋白),以100个细胞/孔进行传代培养,并将与T抗原反应的培养物合并。这些培养物很快失去特异性抗体分泌,可能是由于未知特异性克隆的过度生长。通过有限稀释克隆三次的与T抗原反应的LC分泌量为0.2 - 6.1微克/毫升/10⁶个细胞/24小时,但在培养77至155天后死亡或停止分泌特异性免疫球蛋白。与未合并的克隆相比,在每个克隆步骤后合并与T抗原反应的克隆并没有提高长期稳定性(p = 0.2)。在使用七个不同LC系的十次尝试中有九次,克隆的LC与653细胞之间的融合未能产生活的杂交体。相比之下,未克隆的LC与653细胞的融合在24次融合中有22次产生了分泌免疫球蛋白的活的异源杂交体。从未克隆的与T抗原反应的培养物与653细胞融合产生的异源杂交瘤分泌的抗体明显更多(分泌大于2微克/毫升/10⁶个细胞/24小时的细胞系频率,p小于0.01),并且抗体滴度更高(分泌大于四个T抗原特异性抗体血凝单位的细胞系频率,p小于0.03),比克隆的淋巴母细胞高。与克隆或未克隆的淋巴母细胞系相比,杂交体在培养中维持特异性免疫球蛋白分泌的时间更长(p小于0.001)。